| Product Information |
|
| Registration Number |
VR-4134
|
| Generic Name |
Live Recombinant Marek's Disease (MD) + Newcastle
Disease (ND) Vaccine (Vet.)
|
| Brand Name |
Vectormune HVT NDV & Rispens
|
| Dosage Strength |
Formulation:
Each dose (In-Ovo/SC) contains:
Marek's Disease serotype 3 (FC-126 Strain)-Newcastle Disease (F gene, D-26 - >2474 PFU* Lentogenic Strain) Marek's Disease Virus, serotype 1 (CV1988 Strain)- >1206 PFU* *PFL-Plaque Forming Units
|
| Dosage Form |
Suspension for Injection (In-Ovo/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Type I glass ampoules x 1000, 2000 and 4000 doses +
diluent in PVC bag x 200 mL, 400 mL, 800 mL, 1000 mL,
1200 mL, 1600 mL, 1800 mL and 2400 mL
|
| Pharmacologic Category |
Veterinary Vaccine
|
| Manufacturer |
Biomune Company
|
| Country of Origin |
U.S.A.
|
| Trader |
N/A
|
| Importer |
Ceva Animal Health (Philippines), Inc.
|
| Distributor |
Ceva Animal Health (Philippines), Inc.
|
| Application Type |
Renewal
|
| Issuance Date |
11 February 2022
|
| Expiry Date |
11 February 2027
|